Abstract:Introduction Intra-aortic balloon pump (IABP) has been used since 1960s. Randomized controlled trials demonstrated neither benefit nor harm with IABP use in cardiogenic shock complicating acute coronary syndrome (ACS-CS). However, the clinical trajectory of non-ischemic cardiogenic shock (NI-CS) differs significantly from ACS-CS. There has been increasing interest in the use of IABP to stabilize patients with NI-CS. We aimed to study trends in outcomes of IABP use in NI-CS. Method This is a retrospective cohort analysis using 2016 to 2020 National Inpatient Sample. The International Classification of Diseases, Tenth Revision (ICD- 10) Clinical Modification codes and Procedure codes were used to identify adult patients (equal or >18 years) with NI-CS who were managed with IABP solely. We excluded patients with STEMI, NSTEMI and any revascularization procedures during their hospitalization as well as patients that received other percutaneous ventricular assist devices including Impella or extracorporeal membrane oxygenation. Pearson Chi-square and t-test were used for data analysis. Results We identified 5,533 hospitalizations with NI-CS that were managed with IABP solely during the study period. The rate of admissions for NI-CS managed with IABP increased from 17.9% in 2016 to 21.5% in 2020, p trend<0.001. Mean age was 64 ±14 years. The majority were men (66%). Racial distributions were White (66%), Black (16%), Hispanic (9%) and Asian (4%). The 3,689 (67%) hospitalizations had a Charlson comorbidity index (CCI) of equal or >3. The most common comorbidities found were chronic heart failure (76%), hypertension (62%), atrial fibrillation (42%), chronic kidney disease (40%) and diabetic mellitus (40%). Other comorbidities were chronic pulmonary disease (16%), obstructive sleep apnea (11%) and pulmonary hypertension (7%). Most NI-CS admissions received IABP at urban teaching hospitals, compared to rural hospitals (84% vs 3%, p<0.001). The in-hospital mortality rates decreased from 31.1% in 2016 to 21.7% in 2020, p trend<0.001, however, the overall mortality was still remarkably high (26%). There was no statistically significant difference in trends of length of stay (14 days in 2016 vs 16 days in 2020, p =0.194). Conclusion During the study period, there was decreasing trends in in-hospital mortality despite increased hospitalizations with NI-CS that were managed with IABP solely. Further studies are needed to evaluate the role of IABP use in NI-CS.

The use of pulmonary artery catheter and clinical outcomes in older adults with cardiogenic shock

EFFECT OF PULMONARY ARTERY CATHETERIZATION IN PATIENTS WITH NONISCHEMIC CARDIOGENIC SHOCK: A NATIONWIDE ANALYSIS

The efficacy of pulmonary artery catheters in reducing mortality in acute heart failure cardiogenic shock: A systematic review

Effectiveness of pulmonary artery catheter monitoring for patients with cardiogenic shock of various causes: a systematic review and meta-analysis

INVASIVE HEMODYNAMIC MONITORING WITH PULMONARY ARTERY CATHETER IN SEPSIS-ASSOCIATED CARDIOGENIC SHOCK

Clinical Outcomes of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention in Octogenarians With Coronary Artery Disease.

Abstract 18298: 10-Year Trends of In-Hospital Outcomes of Patients That Underwent Percutaneous Coronary Intervention for Cardiogenic Shock Complicating Acute Coronary Syndrome

Impact of Perioperative Pulmonary Artery Catheter Use on Clinical Outcomes After Cardiac Surgery: A Nationwide Cohort Study

Current Use and Impact of Pulmonary Artery Catheters on the Short-Term Outcomes in Patients With Cardiogenic Shock Treated With an Impella: Findings From the Japan Registry for Percutaneous Ventricular Assist Device (J-PVAD)

Percutaneous Microaxial Ventricular Assist Device Versus Intra-Aortic Balloon Pump for Nonacute Myocardial Infarction Cardiogenic Shock

Short and Mid-Term Economic Impact of Pulmonary Artery Catheter Use in Adult Cardiac Surgery: A Hospital and Integrated Health System Perspective

Impacts of Hospital Volume and Patient-Hospital Distances on Outcomes of Older Adults Receiving Percutaneous Microaxial Ventricular Assist Devices for Cardiogenic Shock

Safety Of Mechanical Circulatory Support Use For Acute Myocardial Infarction Cardiogenic Shock Among Octogenerians: A Nationwide Cohort Analysis Of United States

Association of pulmonary artery capacitance with long-term outcomes in acute coronary syndrome patients with left ventricular systolic dysfunction

[The Application of Pulmonary Artery Catheterization in Treatment of Septic Shock Patients].

Association Between Arterial Pulse Waveform Analysis and Mortality in Patients With Septic Shock: A Retrospective Cohort Study Using Japanese Diagnosis Procedure Combination Data

Pulmonary Artery Catheter in Patients with Severe Acute Pancreatitis: A Single-Center Retrospective Study

Five-year Trends In Outcomes Of Intra-aortic Balloon Pump Use In Non-ischemic Cardiogenic Shock

Intra‐aortic Balloon Pump on In‐hospital Outcomes of Cardiogenic Shock: Findings from a Nationwide Registry, China

Patients aged 90 years and above with Acute Coronary Syndrome in the Cardiac Intensive Care Unit: Management and Outcomes

Trends in Mechanical Circulatory Support Use and Outcomes of Patients With Cardiogenic Shock in Japan, 2010 to 2020 (from a Nationwide Inpatient Database Study)